Shares of GeoVax Labs Inc (GOVX) have been on a tear, rallying over 225% in the past week. The surge can be attributed to increased investor interest in healthcare stocks related to mpox (monkeypox). This surge follows the World Health Organization (WHO)’s declaration of a public health emergency due to an mpox outbreak in Africa.
Last week, the WHO determined that the recent surge of mpox cases across numerous countries in Africa constituted a public health emergency of international concern under International Health Regulations. The WHO Director-General stated, “The emergence of a new clade of mpox, its rapid spread in eastern DRC, and the reporting of cases in several neighbouring countries are very worrying. On top of outbreaks of other mpox clades in DRC and other countries in Africa, it’s clear that a coordinated international response is needed to stop these outbreaks and save lives.”
GeoVax Labs is a clinical-stage biotechnology company focused on developing immunotherapies and vaccines against cancers and infectious diseases. The company’s previous research published in peer-reviewed journals suggests that its vaccines could be effective in preventing mpox.
Analysts are taking notice. EF Hutton analyst Jason Kolbert maintained a Buy rating on GeoVax with a price target of $18 on Monday. GeoVax is scheduled to present at the upcoming Emerging Growth Conference on Wednesday and Thursday, providing shareholders and the investment community an opportunity to interact with the company’s chairman and CEO, David Dodd.
How to Buy GOVX Stock
For those interested in participating in the market for GeoVax, whether by purchasing shares or attempting to short the company, here’s a guide:
*
Buying Shares:
The typical method is through a brokerage account. You can find a list of potential trading platforms online. Many platforms allow fractional share purchases, allowing you to own portions of stock without buying an entire share. For instance, with GeoVax currently trading at $10.68, an investment of $100 would buy you approximately 9.36 shares.*
Shorting Shares:
This is a more complex process requiring access to an options trading platform or a broker who allows short-selling. Shorting involves borrowing shares to sell with the expectation of repurchasing them at a lower price later. It’s a high-risk strategy with potential for significant losses.Alternatively, if your broker offers options trading, you can either buy a put option or sell a call option at a strike price above the current trading price. Both strategies allow you to profit from a decline in the share price.
GOVX Price Action:
On Monday, GeoVax shares closed at $10.68, representing a 51.3% increase, according to Benzinga Pro.
